Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.
GermanyStudy on the Effects of Povorcitinib for Adults with Moderate to Severe Asthma Not Well Controlled
GermanyStudy Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab
FranceStudy on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis
FranceStudy on Aspirin (D,L-Lysine Acetylsalicylate) for Patients with Immune Thrombocytopenia and Cardiovascular Disease
FranceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments
FranceStudy of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus
BulgariaStudy on the Effects of GSK3915393 for Patients with Idiopathic Pulmonary Fibrosis
FranceStudy on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy
CzechiaStudy on the Safety and Efficacy of PF-06835375 and Diphenhydramine Hydrochloride for Adults with Moderate to Severe Primary Immune Thrombocytopenia
CzechiaStudy on Tiotropium for Preventing Severe Asthma Attacks in Preschool Children with Uncontrolled Asthma
GermanyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
